Sidebar
Sep 2009

How does the drug industry create marketing that consumers actively chose to engage with?

keykeyboard
According to Forrester 48% of consumers today now believe that they have the right to decide whether or not to receive advertising. Anyone who still believes in push marketing needs to retire to the markters old age home and watch reruns of The Lucy Show. The Internet has led to a revolution in consumerism where consumers are fighting back against meaningless, interruptive marketing with their own voices through the power of social media and the Web. Read More...
|

TV advertising: DOA

images
DTC marketers love affair with TV advertising maybe forced to come to an end as ROI for TV ads continue to drop. Not only are consumer marketer realizing that TV ads are providing a really bad ROI, most are trying to shift a LOT of money to digital while pharma once again is behind the changes and evolution of marketing to today's consumers. Read More...
|

You don't need big budgets and TV to launch new drugs..

images-1
With DTC spending down by double digits a lot of DTC marketers are going to be facing the reality of doing more with less next year. Someone recently asked me "can you launch a brand online?" and my answer to that is absolutely. Not only can you launch a new pharma product online but I can reach more people online and get a better ROI through interactive than with ANY other channel. Read More...
|

Along the way something happened

images
Some people in pharma remember the 90's as a great time to be in pharma marketing. DTC advertising was permitted and drugs like Prozac, Viagra and Lipitor took off DTC marketing took shape. Times were good, people earned good salaries, bonuses were good and more and more money began to flow into DTC budgets as sales increased. But something else was happening as well; a fundamental shift in the way pharma thought of the business from patient centric to Wall Street centric. Read More...
|

Why social media integration doesn't matter for DTC marketers

images
Recently a friend of mine within the drug industry sent me the metrics for his website from his IT group. It consisted of 5 lines of data showing visitors, number of pages viewed and average number of visitors per day. When I asked him about more detailed data he responded with "that's all I have". Since this product is a $500 million drug I thought there would be more but this is one of the key reasons why pharma doesn't get it and is not ready for the digital revolution. Read More...
|

Amgen getting ready to launch osteoporosis drug with unbranded site

me34
Be afraid..be very afraid ! Amgen is getting ready to launch their osteoporosis drug later this year and they have already started some premliminary marketing with an unbranded site knowmybones.com. The FDA did their best to handcuff Amgen's new drug but if they are marketing savvy it could be a winner but their unbranded sites shows that they have a lot of work to do. Read More...
|

How digital personalized patient ed could work

me32
Click to enlarge

Read More...
|

Another conference more obvious insights

captain-obvious
It's become fun to hear the speakers promote, I mean present insights to pharma marketers about how to market in an era of empowered patients. Today's insights? Pharma needs more people who grew up digital, social media means learning to listen and physicians want materials they can give to patients after diagnosis. The obvious is that which is never seen until someone expresses it simply. Read More...
|

Drug companies involvement in social media is contingent upon the risk they are willing to take to help patients

images
You can’t blaze new paths without going deep in the woods. If the drug industry really believes that social media can benefit patients than they should be willing to risk a letter from the FDA and fight back for its customers. Today it seems every drug company wants to stay far under the radar of the FDA even though the FDA might not understand new media and empowered patients. This approach is leading to marketing practices that are dated and does not consider what is best for the consumer. The real issue is can the drug industry use social media to inform and educate without a marketing person getting in the way and trying to sell someone. Read More...
|

Can big pharma embrace open branding?

me31
Engagement, transparency, brand aggregators, these are all the elements of marketing to today's consumers but it requires a completely new way to think about your customers and an approach that many pharma marketers may not be willing to take as they continue to hide behind "we're a regulated industry". Read More...
|

What the drug industry needs to do now to survive

iStock_000005304585XSmall
What does the drug industry need to do NOW to ensure their survival in the future and where is the industry headed ? The lack of visionaries who are able to install a sense of urgency and change within pharmaceutical marketing is amazing considering that most CEO's earn enough money in one year to retire on. Here are some key points that pharma needs to embrace to stay relevant in the coming decade. Read More...
|

Lifestyle-induced chronic illness conditions increasing medial costs in the US

screenshot_01
The fundamental nature of medical risk in the United States has changed over the past 20 to 30 years—shifting away from random, infrequent, and catastrophic events driven by accidents, genetic predisposition, or contagious disease and toward behavior- and lifestyle-induced chronic conditions. Treating them, and the serious medical events they commonly induce, now costs more than treating the more random, catastrophic events that health insurance was originally designed to cove. What’s more, the number of people afflicted by chronic conditions continues to grow at an alarming rate. This quote from the McKinsey Quarterly ought to send a wake up call to everyone who has something to do with the healthcare industry. Read More...
|

Social media drug marketing maybe an oxymoron

images-1
Those of us who have worked in pharma/medical device industries know all too well that you don't get a cup of coffee without doing an ROI analysis. One of the many reasons that big pharma is in trouble is that their ROI analysis has taken control of too many marketing programs at a time when consumers are saying "I am not a segment". According to eMarketer 84% of professionals do not measure ROI for social media and you had better believe that one of the biggest barriers to pharma doing anything on social media is going to be "how do we calculate ROI?" Read More...
|

Social media is not the answer to DTC marketers problems

images
Consumers today are telling companies "if you aren't open with me, I won't trust you". Trust and transparency have become essential building blocks for any branding campaign and big pharma is not trusted by consumers as the healthcare debate gets more intense. There is however a bigger issue here: the need for transparency. Without transparency even great social media marketing efforts are going to be wasted on an audience that is skeptical of the message. Read More...
|

The FDA has decided to call a public hearing on the use of social media/Web 2.0

iStock_000005304585XSmall
Quick someone call the Cost Guard and let them know the Titanic is in trouble ! Too late? Well that is exactly the FDA response to their public forum on Web 2.0 and social media for pharma marketers. Sure, it's a step in the right direction but here's news to the FDA: Web 2.0 has come and gone and consumers don't want to hear from pharma marketers on social media unless they listen and bring people together. That sound you hear is hell freezing over as people really believe this will lead to new DDMAC guidelines. Read More...
|

When marketing and science collide. How are consumers supposed to determine the real truth?

images-1
Lipitor is the best selling prescription drug of all time with sales in excess of $10 billion but is this drug truly a miracle wonder or is it twisted marketing and defensive medicine gone wrong? If these medications were without side effects, then you may be able to justify the risk - but they cause muscle damage, sexual dysfunction, liver and nerve damage,e and other problems in 10-15% of patients who take them. It has risks and too may people maybe taking this drug when they should be cutting down on the real enemy: sugar. Read More...
|

A great tool to understand social media & your brand

stuuf_01
If you're a pharma marketer you know how important social media is and that it's a great platform to listen to what consumers are saying about your brand but how do you get a handle on what social media is important and identify key influencers and threats to your brand? I just may have an answer in Spiral16 an amazing social media monitoring service that provides marketers with an easy to understand dashboard of what's going on within the social media world around your brand. Read More...
|

DTC marketers continue to talk to the wall as the possible demise of DTC marketing looms

wall
There are two stories this week which possible point to a demise, or at the very least a big cutback, in DTC spending. The first was that Lunesta sales continue to rise despite the fact they are not doing any major DTC advertising. The second was the announcement of 5,500 layoffs at Lilly as drugs in the pipeline fail and the impending loss of $1 billion in sales from the loss of Zyprexa as it comes off patent. If you think cuts in DTC this year were bad just wait till 2010. Read More...
|

Any change, even a change for the better, is always accompanied by drawbacks and discomforts

images
The news about Lilly's planned layoffs of 5,500 people spread like a California wildfire on Cafe Pharma. With the loss of over $1 billion in sales from Zyprexa coming off patent the CEO of Lilly decided that it's time to act like a $20 billion company and accept an environment that is not conducive to growth. People are always telling me that change is good. But all that means is that something you didn't want to happen has happened. Read More...
|

Is Twitter dumbing the message on healthcare or are people really this dumb?

Bury Obama Care
The growth of Twitter has been amazing and it seems that conservatives have seized this social media platform to spread misinformation about healthcare to the point that people don't want to check facts and form their own opinions. Some of the images from the march this weekend in Washington clearly showed that there are a lot of ignorant people in our mist and that the message is being blocked by those who feel it is better to divide our country than provide healthcare for one of the wealthiest nations on Earth. Read More...
|

Respect for your customers and audience

images
There were e-mails that Merck knew about these effects since 1999 and they weren't putting any warnings on the drugs. This is a quote from one of the jurors in Merck Fosamax case. Although the result of the case was a mistrial it is a further indication that sales come before patients safety and health in this authors opinion. Read More...
|

Why do DTC marketers continue to spend (waste) so much money on TV?

art.squirrel.natgeo
According to a case study by Coke Oasis, 3 out of 4 of the top media vehicles for increased brand fame are online. DTC marketers please take note.. ONLINE not via TV ! With Manhattan Research confirming that more people are online looking for health information than ever before why in the hell would you continue to spend most of your DTC budget on TV when it provides such a poor ROI ? Read More...
|

2009 Survey of Health Care Consumers: Health care is a consumer market

screenshot_01
The 2009 Survey of Health Care Consumers, conducted by the Deloitte Center for Health Solutions, is Deloitte’s second- annual study of health care consumers’ attitudes, behaviors and unmet needs. Among the key findings is what a lof of us have known for a long time; patients are becoming consumers of healthcare. Read More...
|

Pfizer settlement a cattle call for more whistleblowers who want a big payday ?

images
With the whistleblowers scheduled to receive a LOT of money from the recent Pfizer settlement I knew it was just a matter of time before more people, hoping for a big payout, would be coming out of the woodwork. Now salespeople are saying that Pfizer promoted several drugs off label. When will it stop and are these claims true or just zealous salespeople trying to cash in? Read More...
|

DTC At The Crossroads

iStock_000003830514XSmall
As we enter the last quarter of 2009 I'm sure a lot of DTC marketers will be saying "goodbye and good riddance". This has been a rough year for drug and medical device companies but there are a lot of challenges that lay ahead. Will DTC marketers chose the road of irrelevance or will they finally understand concepts like patient empowerment ? Read More...
|

Patients do not want to use social media to talk to docs

Perhaps the reason people don't want to use social media to talk to their doctor is that they prefer a communication channel with at least a little privacy ?!

screenshot_01

|

Obama's health care message hard to control=key lesson: You don't control your message anymore

images
Do people check out statements made by bloggers, Twitter users or e-mailers before considering them factual? Social media noise can drown out the facts and the fact is that there is a lot of noise about both the healthcare debate and a variety of prescription drugs.

Read More...
|

There was a time when we were proud to wear drug company shirts

images
There was a time not too long ago when I was proud to wear my Cialis DTC team shirt or Eli Lilly shirt to show people that I worked in the drug industry but I'm not too sure that is the case anymore. The drug industry continues to move from stormy seas to the eye of the hurricane. Read More...
|

More Stuff